Injectable hydromorphone now approved to treat opioid addiction
Canada is the first country to approve the pain drug for severe opioid use disorder, a result of research led by CHÉOS and PHC scientists and staff.
Read MoreMay 2, 2019
Canada is the first country to approve the pain drug for severe opioid use disorder, a result of research led by CHÉOS and PHC scientists and staff.
Read More
Dr. Eugenia Oviedo-Joekes has been examining the effectiveness of patient-centred care (PCC) for people seeking treatment for substance use disorder.
Read More
International Overdose Awareness Day spreads the message that the tragedy of overdose death is preventable. Read more to learn about PORTIA, the follow-up study to NAOMI, SALOME, and RUTH
Read More
The results of the SALOME trial show chronic heroin addiction now has another effective treatment tool – hydromorphone, a licensed pain medication.
Read More
On November 28th, CHÉOS is co-hosting a seminar where attendees will hear from two experts in the field about gathering and utilizing this type of information.
Read More